资讯

PharmaTimes2 小时
Shane Olwill
Asgard Therapeutics has appointed Shane Olwill as Chief Development Officer Asgard Therapeutics, a privately held biotech ...
PharmaTimes3 小时
AviadoBio opens UK trial for FTD gene therapy
AviadoBio has launched its phase 1/2 Aspire-FTD trial in the UK, assessing AVB-101, a gene therapy targeting frontotemporal ...